HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Daniel Serón Selected Research

Mycoses (Diseases, Fungus)

7/2009Low serum mannose-binding lectin as a risk factor for new onset diabetes mellitus after renal transplantation.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Daniel Serón Research Topics

Disease

13Inflammation (Inflammations)
03/2024 - 05/2004
11Proteinuria
09/2022 - 12/2003
7Infections
01/2021 - 07/2009
6Cardiovascular Diseases (Cardiovascular Disease)
01/2021 - 07/2006
5Neoplasms (Cancer)
01/2022 - 11/2003
3Fibrosis (Cirrhosis)
11/2022 - 04/2010
3Acute Kidney Injury (Acute Renal Failure)
01/2022 - 11/2003
3COVID-19
05/2021 - 01/2021
3Delayed Graft Function
04/2021 - 11/2003
3Hypertension (High Blood Pressure)
01/2021 - 11/2003
3Diabetes Mellitus
11/2018 - 09/2006
3Necrosis
05/2012 - 12/2008
2Atrophy
11/2022 - 04/2010
2Focal Segmental Glomerulosclerosis (Glomerulosclerosis, Focal)
05/2021 - 02/2021
2Renal Insufficiency (Renal Failure)
10/2014 - 08/2004
2Hepatitis C
04/2014 - 09/2009
2Chronic Kidney Failure (Chronic Renal Failure)
01/2013 - 06/2010
1Hematoma
03/2022
1Fistula
03/2022
1Melanoma (Melanoma, Malignant)
01/2022
1Lung Neoplasms (Lung Cancer)
01/2022
1Vasculitis (Vasculitides)
05/2021
1Interstitial Nephritis (Tubulointerstitial Nephritis)
05/2021
1Nephrotic Syndrome (Syndrome, Nephrotic)
02/2021
1Type 2 Diabetes Mellitus (MODY)
01/2021
1Chronic Obstructive Pulmonary Disease (COPD)
01/2021
1Left Ventricular Hypertrophy (Ventricular Hypertrophy, Left)
12/2016
1Anemia
10/2013
1Hyperkalemia
08/2013
1Chronic Renal Insufficiency
08/2013
1Hepatocellular Carcinoma (Hepatoma)
10/2012
1Thrombotic Microangiopathies
02/2012
1Hemolysis
02/2012
1Shock
02/2011
1Coinfection
02/2011
1Glomerulonephritis
06/2010
1Ischemia
09/2009
1Mycoses (Diseases, Fungus)
07/2009
1Membranoproliferative Glomerulonephritis (Membranoproliferative Glomerulonephritis, Type II)
08/2006
1Coronary Artery Disease (Coronary Atherosclerosis)
07/2006
1Myocardial Infarction
07/2006

Drug/Important Bio-Agent (IBA)

8CreatinineIBA
09/2022 - 12/2003
7Tacrolimus (Prograf)FDA LinkGeneric
03/2024 - 10/2004
4Proteins (Proteins, Gene)FDA Link
11/2022 - 08/2011
4Calcineurin InhibitorsIBA
03/2021 - 05/2007
3AntibodiesIBA
09/2022 - 11/2003
3Hemoglobins (Hemoglobin)IBA
03/2022 - 10/2013
3Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA
01/2021 - 12/2008
2HLA Antigens (Human Leukocyte Antigens)IBA
03/2024 - 04/2021
2Cyclosporine (Ciclosporin)FDA LinkGeneric
11/2018 - 01/2014
2EverolimusFDA Link
12/2016 - 05/2007
2SteroidsIBA
01/2016 - 01/2014
2Angiotensin Receptor AntagonistsIBA
08/2013 - 12/2008
2TOR Serine-Threonine KinasesIBA
10/2012 - 05/2007
2Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
08/2011 - 07/2009
2Immunosuppressive Agents (Immunosuppressants)IBA
09/2009 - 05/2007
1tocilizumab (atlizumab)FDA Link
09/2022
1cyclopropapyrroloindoleIBA
01/2022
1B7-H1 AntigenIBA
01/2022
1Omalizumab (Xolair)FDA Link
05/2021
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
05/2021
1Immune Checkpoint InhibitorsIBA
05/2021
1Biomarkers (Surrogate Marker)IBA
02/2021
1Ramipril (Altace)FDA LinkGeneric
01/2021
1Angiotensin-Converting Enzyme 2IBA
01/2021
1Immunoglobulins (Immunoglobulin)IBA
03/2020
1Mycophenolic Acid (Cellcept)FDA LinkGeneric
12/2016
1Antiviral Agents (Antivirals)IBA
04/2014
1olmesartanIBA
08/2013
1PotassiumIBA
08/2013
1EnalaprilFDA LinkGeneric
08/2013
1Dihydrotachysterol (AT 10)IBA
01/2013
1eculizumabFDA Link
02/2012
1Complement System Proteins (Complement)IBA
02/2012
1Complement Inactivating AgentsIBA
02/2012
1InterferonsIBA
06/2010
1Interleukin-10 (Interleukin 10)IBA
04/2010
1Poly (ADP-Ribose) Polymerase-1IBA
09/2009
1Lipocalin-2IBA
07/2009
1Type II Tumor Necrosis Factor ReceptorsIBA
07/2009
1Sirolimus (Rapamycin)FDA Link
05/2007
1Rituximab (Mabthera)FDA Link
08/2006
1omega-Chloroacetophenone (Mace)IBA
07/2006
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
07/2006
1Angiotensin Receptors (Angiotensin II Receptor)IBA
07/2006
1Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA
08/2004
1Protein Kinases (Protein Kinase)IBA
05/2004
1Triglycerides (Triacylglycerol)IBA
12/2003
1Hepatitis C AntibodiesIBA
12/2003
1serum P-component (CIt)IBA
11/2003

Therapy/Procedure

16Kidney Transplantation
11/2022 - 07/2006
8Transplantation
12/2016 - 11/2003
3Liver Transplantation
10/2014 - 10/2012
2Therapeutics
09/2022 - 06/2010
2Immunotherapy
01/2022 - 05/2021
1Blood Transfusion (Blood Transfusions)
03/2022
1Renal Dialysis (Hemodialysis)
05/2021
1Renal Replacement Therapy (Therapies, Renal Replacement)
01/2021
1Organ Transplantation
04/2014
1Artificial Respiration (Mechanical Ventilation)
02/2011